<h4 style="text-align: center;">Stage 4 - Transparency</h4>
<style>body { font-family: Arial, sans-serif; font-size: 14px; } .table { border-collapse: collapse; width: 60%; margin: auto; } th, td { padding: 10px; text-align: center; background-color: #f2f2f2; } th:first-child, td:first-child { text-align: left; } td { font-size: 12px; } th { font-size: 12px; } h2 { font-size: 14px; }</style>

<table border="0" class="dataframe table">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>count</th>
      <th>mean</th>
      <th>std</th>
      <th>min</th>
      <th>35%</th>
      <th>50%</th>
      <th>max</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>Proactively document transparency information relevant to all stakeholders</th>
      <td>27</td>
      <td>4.41</td>
      <td>0.69</td>
      <td>3</td>
      <td>4</td>
      <td>5</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Identify a method for ongoing audit monitoring, ensuring that accountable parties are aware and capable of taking any required mitigation steps</th>
      <td>27</td>
      <td>4.37</td>
      <td>0.88</td>
      <td>2</td>
      <td>4</td>
      <td>5</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Consider end user experience</th>
      <td>27</td>
      <td>4.33</td>
      <td>0.68</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Ensure that model limitations are communicated to end users and patients</th>
      <td>27</td>
      <td>4.33</td>
      <td>1.00</td>
      <td>2</td>
      <td>4</td>
      <td>5</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Establish specific goals, standards, terms and conditions</th>
      <td>27</td>
      <td>4.30</td>
      <td>0.67</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Consider continuous reporting methods</th>
      <td>27</td>
      <td>4.30</td>
      <td>0.87</td>
      <td>3</td>
      <td>4</td>
      <td>5</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Report effectiveness to end users and key stakeholders</th>
      <td>27</td>
      <td>4.07</td>
      <td>0.73</td>
      <td>2</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Ensure transparency into existing clinical trials</th>
      <td>27</td>
      <td>3.96</td>
      <td>0.94</td>
      <td>2</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Maintain accessibility to project-related and model information</th>
      <td>27</td>
      <td>3.96</td>
      <td>0.76</td>
      <td>3</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
    <tr>
      <th>Consider education/training for small scale implementation end users</th>
      <td>27</td>
      <td>3.89</td>
      <td>1.09</td>
      <td>2</td>
      <td>4</td>
      <td>4</td>
      <td>5</td>
    </tr>
  </tbody>
</table>